Learn how the pharma industry is overcoming hurdles while unleashing a new wave of technologies.
More than 25 cell and gene therapy products have been approved by the FDA, and this burgeoning class of treatments is experiencing its own explosive growth. As more of these potentially curative therapies reach patients, the industry continues to experiment with solutions to grapple with growing pains.
INCLUDED IN THIS TRENDLINE
Boosting the cell and gene therapy workforce with a skilled, localized approach
Janssen and Legend’s longtime collaboration lands a CAR-T win at ASCO
How research into gene sequencing could revolutionize biopharma